Das humane TFN-alpha-bindende humane Antikörper

European patent · EP2397494 · Deleted

Register entry

Publication number
EP2397494
Application number
EP10184622
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 10, 1997
Published
Dec 21, 2011
Granted
Aug 10, 2016
Deleted
Feb 9, 2017
Reason
Maximum term reached
IPC classes
C07K 16/24 (2006.01)
C12N 15/13 (2006.01)
C12N 15/64 (2006.01)
C12N 5/10 (2006.01)
C12N 1/21 (2006.01)
A61K 39/395 (2006.01)
G01N 33/68 (2006.01)
C12N 15/09 (2006.01)
Priority
US 599226 09.02.1996
US 31476 P 25.11.1996
Divided from
EP02022788
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 13, 2017

    Maximum term reached

    Published in Swissreg on 13.02.2017

  2. Aug 10, 2016

    Granted

    Published in Swissreg on 10.08.2016

Parties

Holder

AbbVie Biotechnology Ltd

Clarendon House 2, Church Street, HM 11 Hamilton, BM

Inventor

Salfeld, Jochen G.

North Grafton, MA 01536, US

Allen, Deborah J.

London N17 9YD, GB

Hoogenboom, Hendricus R.J.M.

3500 Hasselt, BE

Kaymakcalan, Zehra

Westboro, MA 01581, US

Labkovsky, Boris

Framingham, MA 01701, US

Mankovich, John A.

Andover, MA 01810, US

McGuiness, Brian T.

Hauxton, Cambridge CB2 5HP, GB

Roberts, Andrew J.

Cambridge, CB1 3AE, GB

Sakorafas, Paul

Shrewsbury, MA 01545, US

Schoenhaut, David

Clifton, NJ 07011, US

Vaughan, Tristan J.

Impington, Cambridge CB4 4NZ, GB

White, Michael

Framingham, MA 01701, US

Wilton, Alison J.

Cambridge, CB3 0HH, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.